Publication | Open Access

A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: A comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervals

MedicineRandomised TrialMetronomic TherapyGynecologyDose IntensityPharmacotherapyPrimary ChemotherapyMetronomic ChemotherapyCancer TreatmentOncologyGynecology OncologyOvarian Cancer